Vor Net Debt from 2010 to 2025

VOR Stock  USD 1.08  0.03  2.70%   
Vor Biopharma Net Debt yearly trend continues to be relatively stable with very little volatility. Net Debt is likely to grow to about 4.1 M this year. Net Debt is the total debt of Vor Biopharma minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals
 
Net Debt  
First Reported
2010-12-31
Previous Quarter
3.9 M
Current Value
4.1 M
Quarterly Volatility
27.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Vor Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vor Biopharma's main balance sheet or income statement drivers, such as Net Interest Income of 8.6 M, Interest Income of 8.6 M or Depreciation And Amortization of 3.4 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.1. Vor financial statements analysis is a perfect complement when working with Vor Biopharma Valuation or Volatility modules.
  
Check out the analysis of Vor Biopharma Correlation against competitors.
To learn how to invest in Vor Stock, please use our How to Invest in Vor Biopharma guide.

Latest Vor Biopharma's Net Debt Growth Pattern

Below is the plot of the Net Debt of Vor Biopharma over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Vor Biopharma's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vor Biopharma's overall financial position and show how it may be relating to other accounts over time.
Net Debt10 Years Trend
Slightly volatile
   Net Debt   
       Timeline  

Vor Net Debt Regression Statistics

Arithmetic Mean(7,080,656)
Geometric Mean5,899,524
Coefficient Of Variation(382.98)
Mean Deviation16,198,254
Median3,530,000
Standard Deviation27,117,764
Sample Variance735.4T
Range106.1M
R-Value(0.29)
Mean Square Error722.5T
R-Squared0.08
Significance0.28
Slope(1,641,349)
Total Sum of Squares11030.6T

Vor Net Debt History

20254.1 M
20243.9 M
20234.3 M
2022-18.8 M
2021-101.8 M
2020-30.2 M
2019-6.5 M

Other Fundumenentals of Vor Biopharma

Vor Biopharma Net Debt component correlations

1.00.90.82-0.49-0.860.740.920.95-0.340.99-0.040.990.240.720.920.78
1.00.890.81-0.54-0.830.740.890.96-0.331.0-0.061.00.240.690.90.74
0.90.890.69-0.25-0.940.510.850.91-0.620.89-0.30.880.330.550.950.86
0.820.810.69-0.46-0.760.850.790.66-0.340.80.350.8-0.310.820.750.66
-0.49-0.54-0.25-0.460.1-0.59-0.21-0.45-0.15-0.56-0.22-0.570.23-0.31-0.150.12
-0.86-0.83-0.94-0.760.1-0.57-0.92-0.790.6-0.820.09-0.81-0.16-0.71-0.96-0.92
0.740.740.510.85-0.59-0.570.680.51-0.280.730.610.73-0.270.890.530.42
0.920.890.850.79-0.21-0.920.680.81-0.390.880.070.860.20.840.950.91
0.950.960.910.66-0.45-0.790.510.81-0.290.96-0.340.960.440.470.890.73
-0.34-0.33-0.62-0.34-0.150.6-0.28-0.39-0.29-0.320.11-0.31-0.09-0.32-0.49-0.57
0.991.00.890.8-0.56-0.820.730.880.96-0.32-0.071.00.250.680.890.72
-0.04-0.06-0.30.35-0.220.090.610.07-0.340.11-0.07-0.07-0.710.59-0.2-0.17
0.991.00.880.8-0.57-0.810.730.860.96-0.311.0-0.070.240.670.880.7
0.240.240.33-0.310.23-0.16-0.270.20.44-0.090.25-0.710.24-0.210.310.31
0.720.690.550.82-0.31-0.710.890.840.47-0.320.680.590.67-0.210.650.63
0.920.90.950.75-0.15-0.960.530.950.89-0.490.89-0.20.880.310.650.95
0.780.740.860.660.12-0.920.420.910.73-0.570.72-0.170.70.310.630.95
Click cells to compare fundamentals

About Vor Biopharma Financial Statements

Vor Biopharma shareholders use historical fundamental indicators, such as Net Debt, to determine how well the company is positioned to perform in the future. Although Vor Biopharma investors may analyze each financial statement separately, they are all interrelated. The changes in Vor Biopharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on Vor Biopharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Debt3.9 M4.1 M
Net Debt To EBITDA(0.03)(0.03)

Additional Tools for Vor Stock Analysis

When running Vor Biopharma's price analysis, check to measure Vor Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vor Biopharma is operating at the current time. Most of Vor Biopharma's value examination focuses on studying past and present price action to predict the probability of Vor Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vor Biopharma's price. Additionally, you may evaluate how the addition of Vor Biopharma to your portfolios can decrease your overall portfolio volatility.